Clinical Trials Directory

Trials / Completed

CompletedNCT04765813

Use of a Smartphone Application (App) to Assist a Cognitive-Behavioral Smoking Cessation Treatment

A Randomized Clinical Trial to Assess the Efficacy of a Psychological Treatment to Quit Smoking Assisted With an App

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
287 (actual)
Sponsor
University of Santiago de Compostela · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled clinical trial examines the effectiveness of a face-to-face\* cognitive-behavioral behavioral treatment to quit smoking enriched with an App. This project aims to innovate in the psychological smoking cessation treatment and increase abstinence rates in the short and long term. \* Due to the COVID-19 the face-to-face treatment will be conducted in an online format.

Detailed description

Psychological treatment (cognitive-behavioral) is a first-line smoking cessation treatment that has proven its efficacy. However, it is necessary to continue investigating to improve smoking outcomes as abstinence and reduce relapse rates. The use of information technologies (ICTs) in the field of health has grown and developed significantly in recent years. Specifically, mobile applications (Apps), aimed at different health-related aspects (mHealth Apps), are a valuable resource. Its use, as a complement to the face-to-face treatment, could help to increase motivation to quit smoking, treatment adherence, and therapeutic activities compliance. mHealth Apps are becoming highly relevant due to their cost-effectiveness and the added attractiveness for many users. Considering this context, the main aim of the present project is to design and assess the efficacy of a cognitive-behavioral treatment (CBT) for smoking cessation enriched with a Smartphone App. A randomized clinical trial will be carried out with a sample of 270 treatment-seeking smokers at the Smoking Cessation and Addictive Disorders Unit of the University of Santiago de Compostela. Participants will be randomly assigned to one of the following groups: 1. The experimental group (CBT + App), in which participants will receive a cognitive-behavioral treatment\* to quit smoking along with an App with active therapeutic components during the treatment and 12 months follow-ups period (n = 135) 2. The control group (CBT), in which participants will receive the same cognitive-behavioral treatment\* along with the use of a Control App (without active components) during the treatment (n = 135). The main hypothesis is that the combination of a cognitive-behavioral psychological treatment to quit smoking and an App with active therapeutic components will obtain higher abstinence rates at the end of treatment and the 12-month follow-up period, compared to the control group \* Due to the COVID-19, the face-to-face cognitive-behavioral treatment will be conducted in an online format

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive-behavioral treatment to quit smoking along with an App with active therapeutic componentsCognitive-behavioral smoking cessation treatment components will be: treatment contract, self-report and graphic representation of cigarette consumption, information about tobacco, stimulus control, activities for the avoidance of withdrawal syndrome, physiological feedback (CO in expired air) on cigarette consumption, nicotine fading (change of cigarette brands each week progressively decreasing the intake of nicotine and tar), and relapse-prevention strategies (assertion training, problem-solving training, change tobacco-related misconceptions, management of anxiety and anger, exercise, weight control, self-reinforcing, and changing irrational beliefs). Participants will use a smartphone App with therapeutic components during the intervention (8 weeks) and follow-up period (time frame: one year).
BEHAVIORALCognitive-behavioral treatment to quit smoking along with a control AppCognitive-behavioral smoking cessation treatment components will be: treatment contract, self-report and graphic representation of cigarette consumption, information about tobacco, stimulus control, activities for the avoidance of withdrawal syndrome, physiological feedback (CO in expired air) on cigarette consumption, nicotine fading (change of cigarette brands each week progressively decreasing the intake of nicotine and tar), and relapse-prevention strategies (assertion training, problem-solving training, change tobacco-related misconceptions, management of anxiety and anger, exercise, weight control, self-reinforcing, and changing irrational beliefs). Participants will use a control smartphone App (only to access session materials) during the intervention period (8 weeks).

Timeline

Start date
2021-09-15
Primary completion
2023-11-10
Completion
2023-11-10
First posted
2021-02-21
Last updated
2023-12-05

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04765813. Inclusion in this directory is not an endorsement.